![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sofosbuvir/ Velpatasvir/ Voxilaprevir for DAA-experienced HCV Patients:
A Systematic Review and Meta-Analysis
|
|
|
EASL 2023 June 21-24 Vienna
#Pooja DEVAN2, #Kai Le Ashley TIONG2, Jean Ee NEO2, Babu P. MOHAN4, Karn WIJARNPREECHA5, Yew Chong Steve TAM6, Nicola COPPOLA7, Carmen
Monica PREDA8, Yu Jun WONG1,2,3
![0625231](../images/062523/062523-15/0625231.gif)
![0625232](../images/062523/062523-15/0625232.gif)
![0625233](../images/062523/062523-15/0625233.gif)
![0625234](../images/062523/062523-15/0625234.gif)
![0625235](../images/062523/062523-15/0625235.gif)
![0625236](../images/062523/062523-15/0625236.gif)
![0625237](../images/062523/062523-15/0625237.gif)
![0625238](../images/062523/062523-15/0625238.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|